title: Treatment of obstructive sleep apnoea improves metabolic conditions and prevents initiation of antiarrhythmic therapy in a patient with atrial fibrillation.
authors.affiliation: Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III, 66421 Homburg/Saar, Germany.
authors.forename: Dominik
authors.initials: D
authors.lastname: Linz
authors.forename: Christian
authors.initials: C
authors.lastname: Ukena
authors.forename: Hans-Ruprecht
authors.initials: HR
authors.lastname: Neuberger
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000175:diagnosis / Q000503:physiopathology / Q000517:prevention & control*; D018880:Atrial Premature Complexes / Q000175:diagnosis / Q000503:physiopathology / Q000517:prevention & control*; D045422:Continuous Positive Airway Pressure; D015716:Electrocardiography, Ambulatory; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D008875:Middle Aged; D011237:Predictive Value of Tests; D012008:Recurrence; D012307:Risk Factors; D012720:Severity of Illness Index; D020181:Sleep Apnea, Obstructive / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents